The Valley Desk

NCT02500407 · Interventional trial

A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Overall registry status Completed

Phase 1 · Phase 2

Conditions Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov